Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Seattle | 11,366 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,366 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4021-4040 of 11,366 trials

CompletedMaximal Suppression of the Androgen Axis in Clinically Localized Prostate CancerProstate cancer (CaP) is the most commonly diagnosed cancer among males in the U.S. and the second leading cause of cancer-related mortality.NCT00298155·Seattle, Washington and 1 other

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

CompletedA Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary HistologyThe purpose of this study is to evaluate the safety and pharmacokinetics and assess the immunogenicity and effectiveness of AGS-16C3F in subjects with renal cell cancer (RCC).NCT01672775·Ann Arbor, Michigan and 8 others

CompletedTailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIVThis study tailors a shared decision making intervention for lung cancer screening in persons living with human immunodeficiency virus (HIV).NCT04682301·Seattle, Washington

Active not recruitingAcalabrutinib for the Treatment of Chronic Graft Versus Host DiseaseThis phase II trial studies how well acalabrutinib works in treating patients with chronic graft versus host disease.NCT04198922·Tampa, Florida and 5 others

RecruitingStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaThe purpose of the study is to evaluate the progression-free survival (PFS) of casdatifan versus placebo when each is given in combination with cabozantinib in adult patients with…NCT07011719·Gilbert, Arizona and 182 others

CompletedPhase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)To determine if priming (giving the first vaccination) with a vaccinia recombinant (HIVAC-1e) provides a significant advantage in immunogenicity (production of antibodies)…NCT00000630·Nashville, Tennessee and 1 other

TerminatedMeasurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement DevicesThis study collects data using non-invasive devices for assessing CSF shunt flow using thermal anisotropy measurements in a prospective study setting.NCT06513572·Orange, California and 7 others

Active not recruitingA Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's DiseaseThe purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety of guselkumab.NCT05347095·Birmingham, Alabama and 153 others

CompletedAcute Renal Failure Trial Network (ATN) StudyThis is a multi-center, prospective, randomized, parallel-group trial of an intensive strategy vs conventional strategy of renal replacement therapy for the treatment of acute…NCT00076219·No. Little Rock, Arkansas and 21 others

CompletedOnvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)The purpose of the phase 1b/2 study is to determine whether Onvansertib given orally daily for 5 consecutive days every 28 days is safe and tolerable in adult patients who have…NCT03303339·Los Angeles, California and 8 others

TerminatedStudy of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)Use of an oral topically-active glucocorticoid with limited side effects will control the gastrointestinal inflammatory process of GVHD and minimize glucocorticoid exposure.NCT00926575·Buffalo, New York and 2 others

CompletedP03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)The purpose of this study was to determine a safe and effective dose of a new gadolinium-based contrast agent (GBCA) P03277 based on the Contrast to Noise Ratio (CNR) when…NCT02633501·Chicago, Illinois and 27 others

TerminatedContrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast CancerEnrolled women will undergo a bilateral Contrast-Enhanced Breast Magnetic Resonance Imaging (CE-BMRI) as per usual clinical practice within 30 days of breast cancer diagnosis.NCT01303419·Seattle, Washington and 4 others

TerminatedT-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)The study is designed as an open-label, single arm Phase III, multicenter trial to evaluate the efficacy and safety of T-Guard treatment in patients with Steroid-Refractory acute…NCT04128319·Duarte, California and 23 others

CompletedA Pharmacokinetic Study of L-697,661 Alone and in Combination With ZidovudinePart 1: To study the potential safety and pharmacokinetic (blood level) effects of zidovudine (AZT) on L-697,661; to obtain additional pharmacokinetic information in humans with…NCT00000628·San Francisco, California and 4 others

Active not recruitingCombination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic LymphomaThis randomized phase III trial compares how well combination chemotherapy works when given with or without bortezomib in treating patients with newly diagnosed T-cell acute…NCT02112916·Birmingham, Alabama and 211 others

CompletedTherapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV MelanomaRATIONALE: Biological therapies, such as therapeutic autologous lymphocytes, may stimulate the immune system in different ways and stop tumor cells from growing.NCT00438984·Seattle, Washington

RecruitingGrowth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)The purpose of this study is to determine whether growth hormone replacement therapy (GHRT) is effective versus placebo in the improvement of Quality of Life in patients with…NCT04867317·Birmingham, Alabama and 15 others

CompletedTrial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIVTo compare the effect of high-dose valacyclovir (1 gram orally twice daily) versus standard-dose acyclovir (400 mg orally twice daily) on the frequency of genital HSV reactivation…NCT00527618·Seattle, Washington

TerminatedA Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALLThis is a pilot study using decitabine and vorinostat before and during chemotherapy with vincristine, dexamethasone, mitoxantrone, and peg-asparaginase in pediatric patients with…NCT01483690·Los Angeles, California and 27 others

PreviousPage 202 of 569Next

in Seattle

Heart Diseasein Seattle